| Pharmaceutical active ingredients: |
| Diatrizoate Sodium |
| Available forms, composition and doses of Urovist Sodium 300: |
| Injectable; Injection; Diatrizoate Sodium 50% |
| Urovist Sodium 300 medical category: |
| Human:Roentgenography |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V08AA01 - Diatrizoic Acid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering PharmaBerlex Laboratories |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Urovist Cysto | Diatrizoate Meglumine | Bayer Schering Pharma; Berlex Laboratories |
| Urovist Cysto Pediatric | Diatrizoate Meglumine | Bayer Schering Pharma; Berlex Laboratories |
| Urovist Meglumine | Diatrizoate Meglumine | Bayer Schering Pharma; Berlex Laboratories |
| Urovist Meglumine DIU / CT | Diatrizoate Meglumine | Bayer Schering Pharma; Berlex Laboratories |
| Urovist Sodium | Diatrizoate Sodium | Bayer Schering Pharma; Berlex Laboratories |
| Uvilon | Piperazine Hydrate | Bayer Schering Pharma |
| Vagitrol-V | Fluocinolone Acetonide; Metronidazole; Nystatin | Bayer Schering Pharma |
| Valette | Dienogest; Ethinyl Estradiol | Bayer Schering Pharma; Jenapharm |
| Valisone | Betamethasone Valerate | Bayer Schering Pharma; Schering-Plough |
| Valisone G | Betamethasone Valerate; Gentamicin Sulfate | Bayer Schering Pharma; Schering-Plough; Valeo Pharma |